Board Change • Jun 28
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 7 non-independent directors. Independent Director Imran Anwer was the last independent director to join the board, commencing their role in 2025. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Tillkännagivande • Apr 15
Descon Oxychem Limited to Report Q3, 2026 Results on Apr 23, 2026 Descon Oxychem Limited announced that they will report Q3, 2026 results on Apr 23, 2026 Valuation Update With 7 Day Price Move • Mar 13
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to PK₨27.28, the stock trades at a trailing P/E ratio of 7.5x. Average trailing P/E is 10x in the Chemicals industry in Pakistan. Total returns to shareholders of 57% over the past three years. Declared Dividend • Feb 28
First half dividend of PK₨2.00 announced Dividend of PK₨2.00 is the same as last year. Ex-date: 9th March 2026 Payment date: 2nd April 2026 Dividend yield will be 13%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by earnings (55% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 13% per year over the past 7 years. However, payments have been volatile during that time. Earnings per share has grown by 11% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Reported Earnings • Feb 26
Second quarter 2026 earnings released: EPS: PK₨0.79 (vs PK₨1.75 in 2Q 2025) Second quarter 2026 results: EPS: PK₨0.79 (down from PK₨1.75 in 2Q 2025). Revenue: PK₨1.21b (down 28% from 2Q 2025). Net income: PK₨138.9m (down 55% from 2Q 2025). Profit margin: 11% (down from 18% in 2Q 2025). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings. Tillkännagivande • Feb 16
Descon Oxychem Limited to Report Q2, 2026 Results on Feb 24, 2026 Descon Oxychem Limited announced that they will report Q2, 2026 results at 12:30 PM, Pakistan Standard Time on Feb 24, 2026 Reported Earnings • Oct 25
First quarter 2026 earnings released: EPS: PK₨0.78 (vs PK₨1.08 in 1Q 2025) First quarter 2026 results: EPS: PK₨0.78 (down from PK₨1.08 in 1Q 2025). Revenue: PK₨1.28b (down 16% from 1Q 2025). Net income: PK₨135.7m (down 28% from 1Q 2025). Profit margin: 11% (down from 13% in 1Q 2025). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 15% per year, which means it is well ahead of earnings. Upcoming Dividend • Oct 06
Upcoming dividend of PK₨2.00 per share Eligible shareholders must have bought the stock before 13 October 2025. Payment date: 12 November 2025. Payout ratio is on the higher end at 81%, however this is supported by cash flows. Trailing yield: 10%. Within top quartile of Pakistani dividend payers (7.2%). Higher than average of industry peers (7.1%). Reported Earnings • Sep 06
Full year 2025 earnings released: EPS: PK₨4.91 (vs PK₨2.90 in FY 2024) Full year 2025 results: EPS: PK₨4.91 (up from PK₨2.90 in FY 2024). Revenue: PK₨6.00b (up 4.5% from FY 2024). Net income: PK₨860.2m (up 70% from FY 2024). Profit margin: 14% (up from 8.8% in FY 2024). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings. Tillkännagivande • Sep 05
Descon Oxychem Limited, Annual General Meeting, Oct 22, 2025 Descon Oxychem Limited, Annual General Meeting, Oct 22, 2025. Location: descon headquarters, 18-km, ferozepur road., lahore Pakistan New Risk • Aug 09
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Pakistani stocks, typically moving 8.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.4% average weekly change). Market cap is less than US$100m (PK₨5.96b market cap, or US$21.1m). Tillkännagivande • Jul 02
Descon Oxychem Limited Announces Chief Executive Officer Changes, Effective June 30, 2025 Descon Oxychem Limited announced that Mr. Muhammad Mohsin Zia, Chief Executive Officer of the Company, tendered his resignation from the post of Chief Executive Officer with effect from June 30, 2025. Mr. Yasir Siddique Sheikh, has been appointed as Chief Executive Officer in place of Mr. Muhammad Mohsin Zia for the balance un-expired term with an immediate effect. New Risk • May 27
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Pakistani stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.2% average weekly change). Market cap is less than US$100m (PK₨5.80b market cap, or US$20.6m). Buy Or Sell Opportunity • May 26
Now 25% undervalued Over the last 90 days, the stock has risen 20% to PK₨33.13. The fair value is estimated to be PK₨44.15, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.1% over the last 3 years. Earnings per share has declined by 6.3%. Valuation Update With 7 Day Price Move • May 16
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to PK₨28.97, the stock trades at a trailing P/E ratio of 6.1x. Average forward P/E is 16x in the Chemicals industry in Pakistan. Total returns to shareholders of 172% over the past three years. Upcoming Dividend • Feb 24
Upcoming dividend of PK₨2.00 per share Eligible shareholders must have bought the stock before 03 March 2025. Payment date: 26 March 2025. Payout ratio is a comfortable 72% but the company is not cash flow positive. Trailing yield: 7.1%. Lower than top quartile of Pakistani dividend payers (9.4%). Lower than average of industry peers (8.0%). Reported Earnings • Oct 19
First quarter 2025 earnings released: EPS: PK₨1.08 (vs PK₨1.14 in 1Q 2024) First quarter 2025 results: EPS: PK₨1.08 (down from PK₨1.14 in 1Q 2024). Revenue: PK₨1.51b (up 1.0% from 1Q 2024). Net income: PK₨189.8m (down 4.7% from 1Q 2024). Profit margin: 13% (in line with 1Q 2024). Revenue is forecast to grow 8.5% p.a. on average during the next 2 years, compared to a 6.8% growth forecast for the Chemicals industry in Pakistan. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. Upcoming Dividend • Oct 01
Upcoming dividend of PK₨2.00 per share Eligible shareholders must have bought the stock before 08 October 2024. Payment date: 06 November 2024. Trailing yield: 9.8%. Lower than top quartile of Pakistani dividend payers (12%). In line with average of industry peers (9.1%). New Risk • Sep 17
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (PK₨3.65b market cap, or US$13.1m). Tillkännagivande • Sep 11
Descon Oxychem Limited, Annual General Meeting, Oct 16, 2024 Descon Oxychem Limited, Annual General Meeting, Oct 16, 2024. Location: at descon headquarters., 18-km,ferozepur road, lahore Pakistan Buy Or Sell Opportunity • May 13
Now 22% overvalued Over the last 90 days, the stock has fallen 5.5% to PK₨21.28. The fair value is estimated to be PK₨17.48, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 31% over the last 3 years. Earnings per share has grown by 36%. Reported Earnings • Feb 28
Second quarter 2024 earnings released: EPS: PK₨0.38 (vs PK₨2.79 in 2Q 2023) Second quarter 2024 results: EPS: PK₨0.38 (down from PK₨2.79 in 2Q 2023). Revenue: PK₨1.40b (down 21% from 2Q 2023). Net income: PK₨66.1m (down 87% from 2Q 2023). Profit margin: 4.7% (down from 27% in 2Q 2023). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 47% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Feb 16
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to PK₨19.94, the stock trades at a trailing P/E ratio of 3.2x. Average trailing P/E is 5x in the Chemicals industry in Pakistan. Total loss to shareholders of 12% over the past three years. Upcoming Dividend • Oct 03
Upcoming dividend of PK₨2.00 per share at 17% yield Eligible shareholders must have bought the stock before 10 October 2023. Payment date: 08 November 2023. Payout ratio is a comfortable 50% and this is well supported by cash flows. Trailing yield: 17%. Within top quartile of Pakistani dividend payers (14%). In line with average of industry peers (15%). Reported Earnings • Sep 27
Full year 2023 earnings released: EPS: PK₨8.00 (vs PK₨2.69 in FY 2022) Full year 2023 results: EPS: PK₨8.00 (up from PK₨2.69 in FY 2022). Revenue: PK₨6.72b (up 58% from FY 2022). Net income: PK₨1.40b (up 197% from FY 2022). Profit margin: 21% (up from 11% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings. Reported Earnings • Apr 29
Third quarter 2023 earnings released: EPS: PK₨1.67 (vs PK₨0.15 in 3Q 2022) Third quarter 2023 results: EPS: PK₨1.67 (up from PK₨0.15 in 3Q 2022). Revenue: PK₨1.70b (up 73% from 3Q 2022). Net income: PK₨293.1m (up PK₨267.4m from 3Q 2022). Profit margin: 17% (up from 2.6% in 3Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Mar 20
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to PK₨27.34, the stock trades at a trailing P/E ratio of 3.9x. Average trailing P/E is 7x in the Chemicals industry in Pakistan. Total returns to shareholders of 127% over the past three years. Reported Earnings • Feb 24
Second quarter 2023 earnings released: EPS: PK₨2.79 (vs PK₨1.36 in 2Q 2022) Second quarter 2023 results: EPS: PK₨2.79 (up from PK₨1.36 in 2Q 2022). Revenue: PK₨1.78b (up 57% from 2Q 2022). Net income: PK₨489.0m (up 105% from 2Q 2022). Profit margin: 27% (up from 21% in 2Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Board Change • Nov 16
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 6 experienced directors. 1 highly experienced director. 3 independent directors (5 non-independent directors). Independent Director Haroon Waheed was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Nov 03
Investor sentiment improved over the past week After last week's 16% share price gain to PK₨25.28, the stock trades at a trailing P/E ratio of 4.6x. Average trailing P/E is 7x in the Chemicals industry in Pakistan. Total returns to shareholders of 116% over the past three years. Reported Earnings • Oct 28
First quarter 2023 earnings released: EPS: PK₨2.96 (vs PK₨0.13 in 1Q 2022) First quarter 2023 results: EPS: PK₨2.96 (up from PK₨0.13 in 1Q 2022). Revenue: PK₨1.70b (up 116% from 1Q 2022). Net income: PK₨518.8m (up PK₨496.4m from 1Q 2022). Profit margin: 31% (up from 2.8% in 1Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 21% per year whereas the company’s share price has increased by 19% per year. Upcoming Dividend • Oct 03
Upcoming dividend of PK₨2.00 per share Eligible shareholders must have bought the stock before 10 October 2022. Payment date: 10 November 2022. Payout ratio is a comfortable 74% and this is well supported by cash flows. Trailing yield: 9.4%. Lower than top quartile of Pakistani dividend payers (11%). Lower than average of industry peers (12%). Reported Earnings • Sep 28
Full year 2022 earnings released: EPS: PK₨2.69 (vs PK₨1.59 in FY 2021) Full year 2022 results: EPS: PK₨2.69 (up from PK₨1.59 in FY 2021). Revenue: PK₨4.25b (up 52% from FY 2021). Net income: PK₨470.9m (up 69% from FY 2021). Profit margin: 11% (up from 9.9% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 18% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Aug 03
Investor sentiment improved over the past week After last week's 17% share price gain to PK₨17.50, the stock trades at a trailing P/E ratio of 9.3x. Average trailing P/E is 5x in the Chemicals industry in Pakistan. Total returns to shareholders of 62% over the past three years. Reported Earnings • Apr 30
Third quarter 2022 earnings released: EPS: PK₨0.15 (vs PK₨0.75 in 3Q 2021) Third quarter 2022 results: EPS: PK₨0.15 (down from PK₨0.75 in 3Q 2021). Revenue: PK₨982.1m (up 24% from 3Q 2021). Net income: PK₨25.7m (down 80% from 3Q 2021). Profit margin: 2.6% (down from 17% in 3Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings. Board Change • Apr 27
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 6 experienced directors. 1 highly experienced director. 3 independent directors (5 non-independent directors). Independent Director Haroon Waheed was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Feb 21
Second quarter 2022 earnings: Revenues and EPS in line with analyst expectations Second quarter 2022 results: EPS: PK₨1.36 (up from PK₨0.52 in 2Q 2021). Revenue: PK₨1.14b (up 61% from 2Q 2021). Net income: PK₨238.1m (up 162% from 2Q 2021). Profit margin: 21% (up from 13% in 2Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has remained flat, which means it is well ahead of earnings. Reported Earnings • Oct 27
First quarter 2022 earnings released: EPS PK₨0.13 (vs PK₨0.099 in 1Q 2021) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: PK₨788.3m (up 27% from 1Q 2021). Net income: PK₨22.4m (up 59% from 1Q 2021). Profit margin: 2.8% (up from 2.3% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings. Upcoming Dividend • Oct 07
Upcoming dividend of PK₨1.00 per share Eligible shareholders must have bought the stock before 14 October 2021. Payment date: 15 November 2021. Trailing yield: 4.4%. Lower than top quartile of Pakistani dividend payers (10%). Lower than average of industry peers (11%). Reported Earnings • Sep 09
Full year 2021 earnings released: EPS PK₨1.59 (vs PK₨2.95 in FY 2020) The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2021 results: Revenue: PK₨2.80b (up 6.2% from FY 2020). Net income: PK₨278.7m (down 33% from FY 2020). Profit margin: 9.9% (down from 16% in FY 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings. Reported Earnings • Apr 24
Third quarter 2021 earnings released: EPS PK₨0.75 (vs PK₨0.81 in 3Q 2020) The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: PK₨793.1m (up 11% from 3Q 2020). Net income: PK₨130.7m (up 2.7% from 3Q 2020). Profit margin: 17% (down from 18% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Mar 10
Investor sentiment deteriorated over the past week After last week's 20% share price decline to PK₨23.43, the stock is trading at a trailing P/E ratio of 10.5x, down from the previous P/E ratio of 13.1x. This compares to an average P/E of 9x in the Chemicals industry in Pakistan. Total returns to shareholders over the past three years are 54%. Reported Earnings • Feb 28
Second quarter 2021 earnings released: EPS PK₨0.52 (vs PK₨0.75 in 2Q 2020) The company reported a decent second quarter result with improved earnings and profit margins, although revenues were weaker. Second quarter 2021 results: Revenue: PK₨705.0m (down 5.0% from 2Q 2020). Net income: PK₨90.9m (up 2.9% from 2Q 2020). Profit margin: 13% (up from 12% in 2Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has increased by 23% per year, which means it is well ahead of earnings. Is New 90 Day High Low • Feb 20
New 90-day low: PK₨30.83 The company is down 5.0% from its price of PK₨32.33 on 20 November 2020. The Pakistani market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 6.0% over the same period. Reported Earnings • Oct 26
First quarter earnings released Over the last 12 months the company has reported total profits of PK₨378.3m, up 74% from the prior year. Total revenue was PK₨2.63b over the last 12 months, up 1.2% from the prior year. Reported Earnings • Oct 02
Full year earnings released - EPS PK₨3.42 Over the last 12 months the company has reported total profits of PK₨418.4m, up 6.6% from the prior year. Total revenue was PK₨2.64b over the last 12 months, down 2.3% from the prior year. Profit margins were 16%, which is higher than the 14% margin from last year. The increase in margin was driven by lower expenses. Is New 90 Day High Low • Sep 25
New 90-day high: PK₨48.36 The company is up 67% from its price of PK₨28.97 on 26 June 2020. The Pakistani market is up 21% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period. 
